Tumor Associated Macrophages Express High-Levels of FLT3 Ligand, Which Induces Activation of FLT3 Signaling That Promotes Survival of Neoplastic Cells in B-Cell Acute Lymphoblastic Leukemia

被引：1
|
作者：
Guo, Yao
Huang, Junbin
Zhang, Dengyang
Zhang, Liqin
Zhao, Yuming
Yu, Liuting
Chang, Zhiguang
Pei, Han Zhong
Chen, Chun
Xue, Hongman
Xu, Xiaojun
Zhao, Zhizhuang Joe
Chen, Yun
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-142093
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Differential response to stem cell factor and FLT3 ligand by FAB subtypes in acute myeloblastic leukemia clonogenic cells.
    Murohashi, I
    Wakao, D
    Yoshida, K
    Jinnai, I
    Yagasaki, F
    Itoh, Y
    Suzuki, T
    Matsuda, A
    Bessho, M
    BLOOD, 2001, 98 (11) : 109A - 109A
  • [32] Ras pathway activation in childhood B-lineage acute lymphoblastic leukemia:: Ras, PTPN11, and FLT3 mutations.
    Cavé, H
    Saba, S
    Philippe, N
    Grardel, N
    Nelken, B
    Norton, L
    Robert, A
    Yacouben, K
    Vilmer, E
    Bertrand, Y
    Preudhomme, C
    BLOOD, 2004, 104 (11) : 51A - 52A
  • [33] High FLT3 expression and IL10 (G1082A) polymorphism in poor overall survival in calla acute lymphoblastic leukemia
    Dayse Maria Vasconcelos de Deus
    Paulo Roberto Eleutério de Souza
    Maria Tereza Cartaxo Muniz
    Molecular Biology Reports, 2013, 40 : 1609 - 1613
  • [34] High FLT3 expression and IL10 (G1082A) polymorphism in poor overall survival in calla acute lymphoblastic leukemia
    Vasconcelos de Deus, Dayse Maria
    Eleuterio de Souza, Paulo Roberto
    Cartaxo Muniz, Maria Tereza
    MOLECULAR BIOLOGY REPORTS, 2013, 40 (02) : 1609 - 1613
  • [35] Flt3 receptor inhibition abolishes constitutive NFκB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia
    Grosjean, Jennifer
    Ades, Lionel
    Bohrer, Simone
    Fenaux, Pierre
    Kroemer, Guido
    BLOOD, 2007, 110 (11) : 718A - 718A
  • [36] Flt3 receptor inhibition reduces constitutive NFκB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia
    Jennifer Grosjean-Raillard
    Lionel Adès
    Simone Boehrer
    Maximilien Tailler
    Claire Fabre
    Thorsten Braun
    Stéphane De Botton
    Alain Israel
    Pierre Fenaux
    Guido Kroemer
    Apoptosis, 2008, 13 : 1148 - 1161
  • [37] Flt3 receptor inhibition reduces constitutive NFκB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia
    Grosjean-Raillard, Jennifer
    Ades, Lionel
    Boehrer, Simone
    Tailler, Maximilien
    Fabre, Claire
    Braun, Thorsten
    De Botton, Stephane
    Israel, Alain
    Fenaux, Pierre
    Kroemer, Guido
    APOPTOSIS, 2008, 13 (09) : 1148 - 1161
  • [38] Targeting LMO2-induced autocrine FLT3 signaling to overcome chemoresistance in early T-cell precursor acute lymphoblastic leukemia
    Tremblay, Cedric S.
    Saw, Jesslyn
    Yan, Feng
    Boyle, Jacqueline A.
    Amarasinghe, Ovini
    Abdollahi, Shokoufeh
    Vo, Anh N. Q.
    Shields, Benjamin J.
    Mayoh, Chelsea
    Mccalmont, Hannah
    Evans, Kathryn
    Steiner, Anna
    Parsons, Kevin
    Mccormack, Matthew P.
    Powell, David R.
    Wong, Nicholas C.
    Jane, Stephen M.
    Lock, Richard B.
    Curtis, David J.
    LEUKEMIA, 2025, 39 (03) : 577 - 589
  • [39] Flt3 Ligand Induces STAT3-Independent Expansion and Activation of Myeloid-Derived Suppressor Cells Able To Promote Heart Allograft Survival.
    Rosborough, B.
    Liu, Q.
    Raich-Regue, D.
    Matta, B.
    Mathews, L.
    Thomson, A.
    Turnquist, H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 410 - 410
  • [40] A novel ligand-independent Flt3 allele drives RANKL expression in a murine model of B-precursor acute lymphoblastic leukemia with CNS dissemination
    Papp, Eniko
    Johnson, Radia
    Merico, Daniele
    Hu, Pingzhao
    Grandal, Ildiko
    Guidos, Cynthia
    Danska, Jayne
    CANCER RESEARCH, 2012, 72
12345